Clinical Trials - March 21, 2014
EMA launches adaptive licensing pilot project
The European Medicines Agency (EMA) is now inviting companies to participate in its adaptive licensing pilot project. Any company who is interested in participating in the pilot are requested to submit ongoing medicine development programmes for consideration as prospective pilot cases, states the agency in a press release. The adaptive licensing approach, sometimes called staggered approval […]
Uncategorized - March 21, 2014
First Baltic Sea Health Summit in Finland
The first ever Baltic Sea Health Summit BSHS 2014 will be held in Finland, in the city of Turku on 3-5 June 2014. The conference and partnering event is aimed at people working in the biotechnology field in Russia and the EU. The theme of the event will be “Turning science into business for tomorrow’s health […]
Uncategorized - March 21, 2014
New type of cell communication regulates tumour growth and blood vessel formation
A new type of cell communication that results in suppressed blood vessel formation and delayed tumour growth has been discovered at Uppsala University. In the present study, published in Developmental Cell, the researchers have studied how an additional molecule participates in the cell communication in response to VEGF. If this molecule, called NRP1, is present on the […]
Drug Development Pharma - March 20, 2014
Lundbeck and Otsuka initiate European launch of Abilify Maintena
The two companies has announced the launch of Abilify Maintena in Europe following approval by the European Commission in November 2013. Denmark is the first European country where Abilify Maintena is fully reimbursed and accessible to people with schizophrenia, and more than ten markets are expected to launch by the end of 2014. Abilify Maintena (aripiprazole) is […]
Drug Development Pharma - March 19, 2014
Novo Nordisk builds new purification pilot plant
Novo Nordisk is increasing its drug development capacity by investing 550 million Danish kroner (100 million US dollars) in a new research and development facility in Bagsværd, Denmark. The purification plant will expand the company’s capacity to produce active pharmaceutical ingredients for a growing number of diabetes drugs under development. The pilot plant will be fully […]
Uncategorized - March 18, 2014
Testing new app for memory impaired in Norway
Welfare technology company Mylifeproducts has initiated a new test project delivering tablets and software to families with relatives with memory impairments in the Bergen region. Teaming up with The Kavli Trust, which provide financing and the National Association for Public Health in the county of Hordaland, which is the local representative and contact point, Mylifeproducts […]
